RVMD – revolution medicines, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

RVMD

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/17

08:42 am

rvmd

Revolution Medicines (NASDAQ:RVMD) had its "overweight" rating reaffirmed by analysts at Benchmark Co..

Medium Report

Revolution Medicines (NASDAQ:RVMD) had its "overweight" rating reaffirmed by analysts at Benchmark Co..

Report

2/17

08:42 am

rvmd

Revolution Medicines (NASDAQ:RVMD) had its "overweight" rating reaffirmed by analysts at Benchmark Co..

Medium Report

Revolution Medicines (NASDAQ:RVMD) had its "overweight" rating reaffirmed by analysts at Benchmark Co..

Report

2/2

01:00 pm

rvmd

Rating for RVMD

Low Report

Rating for RVMD

Report

1/27

09:11 am

rvmd

Rating for RVMD

Low Report

Rating for RVMD

Report

1/27

09:11 am

rvmd

Rating for RVMD

Low Report

Rating for RVMD

Report

1/27

08:08 am

rvmd

Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..

Low Report

Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..

Report

1/22

08:51 am

rvmd

Rating for RVMD

Low Report

Rating for RVMD

Report

1/21

09:25 am

rvmd

Rating for RVMD

Low Report

Rating for RVMD

Report

1/21

09:25 am

rvmd

Rating for RVMD

Low Report

Rating for RVMD

Report

1/21

07:17 am

rvmd

Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.

Low Report

Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.

Report

1/21

07:17 am

rvmd

Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.

Low Report

Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.

Report

1/20

09:10 am

rvmd

Rating for RVMD

Low Report

Rating for RVMD

Report

1/20

09:10 am

rvmd

Rating for RVMD

Low Report

Rating for RVMD

Report

1/20

08:11 am

rvmd

Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.

Low Report

Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.

Report

1/20

08:11 am

rvmd

Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.

Low Report

Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.

Report

1/13

08:32 am

rvmd

Rating for RVMD

Low Report

Rating for RVMD

Report

1/13

08:32 am

rvmd

Rating for RVMD

Low Report

Rating for RVMD

Report

1/9

09:14 am

rvmd

Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Wedbush.

Medium Report

Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Wedbush.

Report

1/9

09:14 am

rvmd

Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Wedbush.

Medium Report

Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Wedbush.

Report

12/9

08:11 am

rvmd

Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.

Medium Report

Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.